Sign In
Buy CKPT
$4.26
+0 (+0%)
At Close: Aug 29, 2025
Checkpoint Therapeutics (CKPT) Investor Presentation - Slideshow
04:01pm, Thursday, 20'th Aug 2020
The following slide deck was published by Checkpoint Therapeutics, Inc. in conjunction with this event..
Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
12:00pm, Monday, 17'th Aug 2020
NEW YORK, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James F.
Checkpoint Therapeutics (NASDAQ:CKPT) vs. Innovus Pharmaceuticals (NASDAQ:INNV) Head to Head Contrast
01:48am, Tuesday, 11'th Aug 2020
Checkpoint Therapeutics (NASDAQ:CKPT) and Innovus Pharmaceuticals (OTCMKTS:INNV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on
HC Wainwright Reiterates Buy Rating for Checkpoint Therapeutics (NASDAQ:CKPT)
07:58am, Sunday, 09'th Aug 2020
Checkpoint Therapeutics (NASDAQ:CKPT)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report issued on Thursday, TipRanks reports. They currently have a $15.0
Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
08:30pm, Wednesday, 05'th Aug 2020
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, de
Checkpoint Therapeutics to Present Cosibelimab Interim Results from Registration-Enabling Trial at ESMO Virtual Congress 2020
11:30am, Monday, 27'th Jul 2020
* Presentation to highlight updated interim data from global trial in patients with metastatic cutaneous squamous cell carcinoma * Over 50% of enrollment target achieved; full enrollment expected a
What We Learned About Checkpoint Therapeutics' (NASDAQ:CKPT) CEO Pay
10:59am, Tuesday, 21'st Jul 2020
This article will reflect on the compensation paid to James Oliviero who has served as CEO of Checkpoint Therapeutics...
Checkpoint Therapeutics’ (CKPT) Buy Rating Reiterated at LADENBURG THALM/SH SH
06:00am, Sunday, 19'th Jul 2020
LADENBURG THALM/SH SH reaffirmed their buy rating on shares of Checkpoint Therapeutics (NASDAQ:CKPT) in a report published on Wednesday, AnalystRatings.com reports. The brokerage currently has a $20.0
Nanobiotix Announces Revenue for Second Quarter 2020 and First Half Year 2020
12:00am, Friday, 17'th Jul 2020
Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneer
3 “Strong Buy” Penny Stocks That Could Rally to $10 (Or More)
07:27pm, Thursday, 16'th Jul 2020
Since June 8, stocks have been moving, but they’ve been going in a sideways direction. While this movement combined with low expectations for Q2 earnings is concerning, one Wall Street pro believes
How R&D Expenses Can Help You Pick Outperforming Stocks
12:13pm, Thursday, 02'nd Jul 2020
A simple two-rule screen can help you pick R&D-intensive stocks primed to outperform. The differences between R&D expenditures and capital expenditures vary bet
Brian Piccolo Remembered On 50th Anniversary Of His Death
03:20am, Saturday, 20'th Jun 2020
A car parade through the streets of North Beverly was held in memory of the former Chicago Bears running back who died of cancer at age 26.
Hedge Funds Are Warming Up To Checkpoint Therapeutics, Inc. (CKPT)
05:42pm, Wednesday, 27'th May 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Top Hong Kong Developer Shares Fall More Than 5% as Beijing Imposes Security Law
07:15am, Sunday, 24'th May 2020
Stocks in Hong Kong’s major developers, including Sun Hung Kai, CK Asset and Wheelock, plunged
Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders
12:30pm, Friday, 22'nd May 2020
Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it will host the Company’s 2020 Annual Meeting of Stockhol
